litlas
ログインアカウント作成

Rohit Loomba

2007–2026 年に発表

484
論文数
96,844
被引用数
153
h 指数
455
i10 指数

被引用数

Rohit Loomba の年別被引用数1944 年: 被引用 1 件1965 年: 被引用 1 件1966 年: 被引用 1 件1983 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件2000 年: 被引用 1 件2001 年: 被引用 4 件2003 年: 被引用 1 件2005 年: 被引用 2 件2007 年: 被引用 3 件2008 年: 被引用 13 件2009 年: 被引用 40 件2010 年: 被引用 33 件2011 年: 被引用 38 件2012 年: 被引用 65 件2013 年: 被引用 82 件2014 年: 被引用 183 件2015 年: 被引用 370 件2016 年: 被引用 568 件2017 年: 被引用 625 件2018 年: 被引用 912 件2019 年: 被引用 2,688 件2020 年: 被引用 4,670 件2021 年: 被引用 5,643 件2022 年: 被引用 5,206 件2023 年: 被引用 5,349 件2024 年: 被引用 10,119 件2025 年: 被引用 6,192 件2026 年: 被引用 280 件1945〜1964 年は被引用が無いため表示していません1967〜1982 年は被引用が無いため表示していません1984〜1995 年は被引用が無いため表示していません1998〜1999 年は被引用が無いため表示していません2002 年は被引用が無いため表示していません2004 年は被引用が無いため表示していません2006 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,826 件、この内訳の 20.1%中国: 引用元論文 5,918 件、この内訳の 17.4%イギリス: 引用元論文 1,781 件、この内訳の 5.2%イタリア: 引用元論文 1,781 件、この内訳の 5.2%ドイツ: 引用元論文 1,371 件、この内訳の 4%日本: 引用元論文 1,043 件、この内訳の 3.1%スペイン: 引用元論文 1,006 件、この内訳の 3%フランス: 引用元論文 994 件、この内訳の 2.9%韓国: 引用元論文 936 件、この内訳の 2.8%カナダ: 引用元論文 822 件、この内訳の 2.4%オーストラリア: 引用元論文 777 件、この内訳の 2.3%インド: 引用元論文 635 件、この内訳の 1.9%
0%20.1%その他 29.7%

機関

分野

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Immunology and Microbiology1.9%
  • Environmental Science0.7%
  • Neuroscience0.7%
  • Nursing0.6%
  • その他3%

トピック

  • Liver Disease Diagnosis and Treatment20.5%
  • Liver Disease and Transplantation5%
  • Diet, Metabolism, and Disease4.2%
  • Gut microbiota and health3.1%
  • Alcohol Consumption and Health Effects2.7%
  • Diet and metabolism studies2.4%
  • その他62.1%

共著者

全論文

検索で開く
  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group - Hepatology 2023 被引用: 2,904

  2. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

    著者: Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, Manal F. Abdelmalek, Stephen H. Caldwell, Diana Barb, David E. Kleiner, Rohit Loomba - Hepatology 2023 被引用: 2,253

  3. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

    著者: Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair M. Younossi, Seth J. Baum, Sven Francque, Michael Charlton, Philip N. Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M. Pericàs, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena B. Bansal, Naim Alkhouri, Laurent Castéra, Madhavi Rudraraju, Vlad Ratziu - New England Journal of Medicine 2024 被引用: 1,701

  4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    著者: Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth M. Brunt, Elisabetta Bugianesi, Hannele Yki‐Järvinen, Henning Grønbæk, Helena Cortez‐Pinto, Jacob George, Jian‐Gao Fan, Luca Valenti, Manal F. Abdelmalek, Manuel Romero‐Gómez, Mary E. Rinella, Marco Arrese, Mohammed Eslam, Pierre Bédossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramón Bataller, Rohit Loomba, Silvia Sookoian, Shiv Kumar Sarin, Stephen A. Harrison, Takumi Kawaguchi, Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 被引用: 3,274

  5. Mechanisms and disease consequences of nonalcoholic fatty liver disease

    著者: Rohit Loomba, Scott L. Friedman, Gerald I. Shulman - Cell 2021 被引用: 1,969

  6. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

    著者: Daniel Q. Huang, Hashem B. El‐Serag, Rohit Loomba - Nature Reviews Gastroenterology & Hepatology 2020 被引用: 1,820

  7. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    著者: Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome - Annals of Hepatology 2023 被引用: 2,698

  8. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

    著者: Chris Estes, Homie Razavi, Rohit Loomba, Zobair M. Younossi, Arun J. Sanyal - Hepatology 2017 被引用: 2,393

  9. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

    著者: Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, Brent A. Neuschwander‐Tetri, Anna‐Mae Diehl, Srinivasan Dasarathy, Rohit Loomba, Naga Chalasani, Kris V. Kowdley, Bilal Hameed, Laura Wilson, Katherine P. Yates, Patricia Belt, Mariana Lazo, David E. Kleiner, Cynthia Behling, James Tonascia - New England Journal of Medicine 2021 被引用: 1,065

  10. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

    著者: Rohit Loomba, Mark L. Hartman, Eric Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W. Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A. Robins, Amir Nikooie, Mathijs C. Bunck, Axel Haupt, Arun J. Sanyal - New England Journal of Medicine 2024 被引用: 783

  11. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    著者: Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi - Journal of Hepatology 2018 被引用: 2,008

  12. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

    著者: Sven Francque, Pierre Bédossa, Vlad Ratziu, Quentin M. Anstee, Elisabetta Bugianesi, Arun J. Sanyal, Rohit Loomba, Stephen A. Harrison, R. Balabanska, Lyudmila Mateva, Nicolas Lanthier, Naim Alkhouri, Christophe Moreno, Jörn M. Schattenberg, Diana Stefanova-Petrova, Luisa Vonghia, Régine Rouzier, Maéva Guillaume, Alexander Hodge, Manuel Romero‐Gómez, Philippe Huot-Marchand, Martine Baudin, Marie‐Paule Richard, Jean‐Louis Abitbol, Pierre Broqua, Jean‐Louis Junien, Manal F. Abdelmalek - New England Journal of Medicine 2021 被引用: 721

  13. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

    著者: Parambir S. Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J. Prokop, Zobair M. Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Per Stål, Vincent Wai‐Sun Wong, Stergios Kechagias, Rolf Hultcrantz, Rohit Loomba - Hepatology 2017 被引用: 1,898

  14. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

    著者: Rohit Loomba, Arun J. Sanyal, Kris V. Kowdley, Deepak L. Bhatt, Naim Alkhouri, Juan P. Frías, Pierre Bédossa, Stephen A. Harrison, Donald J. Lazas, Robert J. Barish, Mildred D. Gottwald, Shibao Feng, Germaine D. Agollah, Cynthia L. Hartsfield, Hank Mansbach, Maya Margalit, Manal F. Abdelmalek - New England Journal of Medicine 2023 被引用: 442

  15. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    著者: Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, Mary E. Rinella, Quentin M. Anstee, Zachary Goodman, Pierre Bédossa, Andreas Geier, Susanne Beckebaum, Philip N. Newsome, David Sheridan, Muhammad Y. Sheikh, James F. Trotter, W Knapple, Eric Lawitz, Manal F. Abdelmalek, Kris V. Kowdley, Aldo J. Montaño‐Loza, Jérôme Boursier, Philippe Mathurin, Elisabetta Bugianesi, G. Mazzella, Antonio Olveira, Helena Cortez‐Pinto, Isabel Graupera, David Orr, Lise Lotte Gluud, Jean‐François Dufour, David E. Shapiro, Jason Campagna, Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey ほか 288 名 - The Lancet 2019 被引用: 1,213

  16. The gut–liver axis and the intersection with the microbiome

    著者: Anupriya Tripathi, Justine W. Debelius, David A. Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight - Nature Reviews Gastroenterology & Hepatology 2018 被引用: 1,424

  17. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

    著者: Rohit Loomba, Manal F. Abdelmalek, Matthew J. Armstrong, Maximilian Jara, Mette Skalshøi Kjær, Niels Krarup, Eric Lawitz, Vlad Ratziu, Arun J. Sanyal, Jörn M. Schattenberg, Philip N. Newsome - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 472

  18. Global epidemiology of cirrhosis — aetiology, trends and predictions

    著者: Daniel Q. Huang, Norah A. Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Rohit Loomba - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 766

  19. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

    著者: Laurent Castéra, Mireen Friedrich‐Rust, Rohit Loomba - Gastroenterology 2019 被引用: 1,471

  20. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    著者: Rohit Loomba, Victor Seguritan, Weizhong Li, Tao Long, Niels Klitgord, Archana Bhatt, Parambir S. Dulai, Cyrielle Caussy, Richele Bettencourt, Sarah K. Highlander, Marcus B. Jones, Claude B. Sirlin, Bernd Schnabl, Lauren Brinkac, Nicholas J. Schork, Chi‐Hua Chen, David A. Brenner, William Biggs, Shibu Yooseph, J. Craig Venter, Karen E. Nelson - Cell Metabolism 2017 被引用: 1,097

  21. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    著者: Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Bilal Hameed, Kris V. Kowdley, Arthur J. McCullough, Norah A. Terrault, Jeanne M. Clark, James Tonascia, Elizabeth M. Brunt, David E. Kleiner, Edward Doo - The Lancet 2014 被引用: 2,185

  22. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

    著者: Siddharth Singh, Alina M. Allen, Zhen Wang, Larry J. Prokop, M. Hassan Murad, Rohit Loomba - Clinical Gastroenterology and Hepatology 2014 被引用: 1,722

  23. Advancing the global public health agenda for NAFLD: a consensus statement

    著者: Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castéra, Helena Cortez‐Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.‐K. Huang, Mona Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary E. Rinella, Diana Romero, Manuel Romero‐Gómez, Jörn M. Schattenberg, Emmanuel Tsochatzis, Luca Valenti, Vincent Wai‐Sun Wong, Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch ほか 121 名 - Nature Reviews Gastroenterology & Hepatology 2021 被引用: 736

  24. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

    著者: Daniel Q. Huang, Amit G. Singal, Yuko Kono, Darren Jun Hao Tan, Hashem B. El‐Serag, Rohit Loomba - Cell Metabolism 2022 被引用: 509